The Novo Nordisk Inc.’s Diabetes Education Program is awarded NCQA Disease Management Certification in Program Design. NCQA Certification is an indication that a Disease Management Program has passed a rigorous review in a specific area, either program design or disease management systems.
The Diabetes Education Program was evaluated on the following 5
NCQA Disease Management standards are intended to help organizations achieve the highest level of performance possible, reduce patient risk, and create an environment of continuous quality improvement.
NCQA Disease Management Certification standards are developed with input from researchers in the field, the Disease Management Advisory Council (DMAC) and standing committee, employers, both purchasers and operators of disease management programs, state and federal regulators, and other experts.